CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 67 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 29.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $76,000 | -54.2% | 30,000 | -50.0% | 0.00% | -57.1% |
Q2 2017 | $166,000 | +24.8% | 60,000 | -11.8% | 0.01% | +40.0% |
Q1 2017 | $133,000 | +87.3% | 68,000 | 0.0% | 0.01% | +66.7% |
Q4 2016 | $71,000 | -4.1% | 68,000 | 0.0% | 0.00% | -40.0% |
Q3 2016 | $74,000 | +51.0% | 68,000 | -1.8% | 0.01% | +25.0% |
Q2 2016 | $49,000 | -65.7% | 69,255 | -43.2% | 0.00% | -33.3% |
Q1 2016 | $143,000 | -52.2% | 122,000 | 0.0% | 0.01% | -71.4% |
Q4 2015 | $299,000 | -18.3% | 122,000 | 0.0% | 0.02% | +31.2% |
Q3 2015 | $366,000 | -31.8% | 122,000 | -6.2% | 0.02% | -23.8% |
Q2 2015 | $537,000 | -16.2% | 130,000 | -12.2% | 0.02% | -25.0% |
Q1 2015 | $641,000 | +34.9% | 148,000 | -7.5% | 0.03% | +75.0% |
Q4 2014 | $475,000 | -4.6% | 160,000 | +6.7% | 0.02% | +33.3% |
Q3 2014 | $498,000 | -6.2% | 150,000 | -28.6% | 0.01% | 0.0% |
Q2 2014 | $531,000 | +135.0% | 210,000 | +110.0% | 0.01% | +140.0% |
Q1 2014 | $226,000 | – | 100,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |